Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?
1 other identifier
interventional
44
1 country
1
Brief Summary
The purpose of this study is to determine if consuming an 8 ounce cup of coffee with breakfast and lunch is effective in preventing or reducing postoperative ileus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 24, 2010
CompletedFirst Posted
Study publicly available on registry
May 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 11, 2013
June 1, 2013
1.7 years
May 24, 2010
June 10, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Resolution of ileus
Measured by hours to first flatus or bowel movement and tolerance of solid food.
a mean difference of 24 hours to be significant
Study Arms (2)
eight ounces of caffeinated coffee for breakfast and lunch
ACTIVE COMPARATORstandard care
NO INTERVENTIONInterventions
8 oz. of caffeinated cofee/breakfast\&noon meal. No intervention for 2nd arm.
Eligibility Criteria
You may qualify if:
- Elective partial bowel resection with primary anastomosis for either cancer or benign disease.
- Laparoscopy or laparotomy
You may not qualify if:
- Total colectomy
- Colostomy
- Ileostomy
- Reversal of a stoma or synchronous resection
- Complete small or large bowel obstruction
- Scheduled to receive other treatments or techniques to reduce ileus
- \. epidural anesthetic tecniques
- Nasogastric tube for any length of timein the post-op period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMass Memorial Medical Center Memorial Campus
Worcester, Massachusetts, 01605, United States
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2010
First Posted
May 26, 2010
Study Start
April 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
June 11, 2013
Record last verified: 2013-06